HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laurent Chambonneau Selected Research

Dengue (Dengue Fever)

1/2022Analysis of Neutralizing Antibodies as a Correlate of Instantaneous Risk of Hospitalized Dengue in Placebo Recipients of Dengue Vaccine Efficacy Trials.
1/2021Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countries.
1/2020Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America.
1/2019Bridging Efficacy of a Tetravalent Dengue Vaccine from Children/Adolescents to Adults in Highly Endemic Countries Based on Neutralizing Antibody Response.
1/2018Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America.
1/2018Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease.
10/2016Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America.
10/2008Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects.
5/2008Age-specific prevalence of dengue antibodies in Bangkok infants and children.
12/2006Dengue virus infections in the first 2 years of life and the kinetics of transplacentally transferred dengue neutralizing antibodies in thai children.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laurent Chambonneau Research Topics

Disease

12Dengue (Dengue Fever)
01/2022 - 02/2004
2Infections
10/2016 - 12/2006
2Typhoid Fever (Typhoid)
11/2005 - 07/2004
1Asymptomatic Infections
10/2016
1Yellow Fever
10/2008
1Hepatitis A (Hepatitis, Infectious)
11/2005
1Asthenia
07/2004
1Headache (Headaches)
07/2004

Drug/Important Bio-Agent (IBA)

10VaccinesIBA
01/2021 - 07/2004
7Dengue VaccinesIBA
01/2022 - 02/2004
5Neutralizing AntibodiesIBA
01/2022 - 12/2006
3CYD-TDV vaccineIBA
01/2019 - 01/2018
2AntibodiesIBA
05/2008 - 12/2006
2Hepatitis A Vaccines (Hepatitis A Vaccine)IBA
11/2005 - 07/2004
1Combined VaccinesIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
10/2016
1AntigensIBA
10/2008
1CytokinesIBA
10/2008
1EpitopesIBA
10/2008